The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy

P. S.C. Rees, S. M. Davidson, S. E. Harding, C. McGregor, P. M. Elliot, D. M. Yellon, D. J. Hausenloy

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)235-237
Number of pages3
JournalCardiovascular Drugs and Therapy
Issue number3
StatePublished - Jun 2013
Externally publishedYes

Bibliographical note

Funding Information:
Acknowledgments The authors are grateful for the support of the British Heart Foundation (grant number FS/06/023). This study was carried out at the Heart Hospital/University College London Hospital and University College London, which received a proportion of funding from the Department of Health’s NIHR Biomedical Research Centres funding scheme.


  • Atorvastatin
  • Ciclosporin-A
  • Hypertrophic cardiomyopathy
  • MPTP
  • Myocardial ischemia-reperfusion injury

Cite this